Iteos Total Assets from 2010 to 2024

ITOS Stock

USD 8.19 0.05 0.61%

Iteos Therapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 496.8 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2019-12-31

Previous Quarter

751.8 M

Current Value

723.1 M

Quarterly Volatility

273.8 M

Covid

Check Iteos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Iteos Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 3.4 M, Net Interest Income of 32.4 M or Interest Income of 32.4 M, as well as many indicators such as Price To Sales Ratio of 32.65, Dividend Yield of 0.0 or PTB Ratio of 0.65. Iteos financial statements analysis is a perfect complement when working with Iteos Therapeutics Valuation or Volatility modules.

Check out the analysis of Iteos Therapeutics Correlation against competitors.

For more information on how to buy Iteos Stock please use our How to Invest in Iteos Therapeutics guide.

Latest Iteos Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Iteos Therapeutics over the last few years. Total assets refers to the total amount of Iteos Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Iteos Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Iteos Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Iteos Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 667.59 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Iteos Total Assets Regression Statistics

	Arithmetic Mean	228,396,160
	Geometric Mean	77,137,153
	Coefficient Of Variation	137.92
	Mean Deviation	267,559,813
	Median	27,391,000
	Standard Deviation	315,004,154
	Sample Variance	99227.6T
	Range	857.3M
	R-Value	0.77
	Mean Square Error	43782T
	R-Squared	0.59
	Significance	0.0008
	Slope	54,116,960
	Total Sum of Squares	1389186.6T

Iteos Total Assets History

	2024	496.8 M
	2023	667.6 M
	2022	755 M
	2021	884.7 M
	2020	344.6 M
	2019	30.7 M

Other Fundumenentals of Iteos Therapeutics

Intangibles To Total Assets

Iteos Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment
Total Assets		0.98	0.92	0.61	-0.88	0.85	0.8	0.74	0.83	0.83	0.98	0.99	-0.84	0.99	-0.27	-0.66	0.94
Total Stockholder Equity	0.98		0.95	0.45	-0.79	0.85	0.84	0.62	0.86	0.71	1.0	0.96	-0.86	1.0	-0.26	-0.67	0.95
Net Tangible Assets	0.92	0.95		0.33	-0.7	0.78	0.96	0.6	0.82	0.65	0.95	0.9	-0.87	0.94	-0.23	-0.66	0.92
Current Deferred Revenue	0.61	0.45	0.33		-0.87	0.42	0.14	0.81	0.35	0.93	0.45	0.67	-0.36	0.51	-0.24	-0.28	0.43
Net Debt	-0.88	-0.79	-0.7	-0.87		-0.58	-0.5	-0.8	-0.68	-0.94	-0.79	-0.92	0.73	-0.83	0.34	0.55	-0.7
Retained Earnings	0.85	0.85	0.78	0.42	-0.58		0.72	0.57	0.59	0.67	0.84	0.81	-0.64	0.83	-0.22	-0.41	0.86
Accounts Payable	0.8	0.84	0.96	0.14	-0.5	0.72		0.53	0.73	0.5	0.84	0.76	-0.76	0.82	-0.11	-0.6	0.87
Net Receivables	0.74	0.62	0.6	0.81	-0.8	0.57	0.53		0.67	0.9	0.61	0.77	-0.37	0.66	0.15	-0.64	0.72
Capital Surpluse	0.83	0.86	0.82	0.35	-0.68	0.59	0.73	0.67		0.58	0.85	0.82	-0.58	0.86	0.2	-0.95	0.85
Total Liab	0.83	0.71	0.65	0.93	-0.94	0.67	0.5	0.9	0.58		0.71	0.87	-0.6	0.76	-0.25	-0.47	0.71
Net Invested Capital	0.98	1.0	0.95	0.45	-0.79	0.84	0.84	0.61	0.85	0.71		0.96	-0.87	1.0	-0.28	-0.65	0.94
Total Current Assets	0.99	0.96	0.9	0.67	-0.92	0.81	0.76	0.77	0.82	0.87	0.96		-0.84	0.98	-0.29	-0.65	0.91
Capital Stock	-0.84	-0.86	-0.87	-0.36	0.73	-0.64	-0.76	-0.37	-0.58	-0.6	-0.87	-0.84		-0.87	0.65	0.33	-0.73
Net Working Capital	0.99	1.0	0.94	0.51	-0.83	0.83	0.82	0.66	0.86	0.76	1.0	0.98	-0.87		-0.28	-0.67	0.94
Short Term Debt	-0.27	-0.26	-0.23	-0.24	0.34	-0.22	-0.11	0.15	0.2	-0.25	-0.28	-0.29	0.65	-0.28		-0.43	-0.05
Common Stock	-0.66	-0.67	-0.66	-0.28	0.55	-0.41	-0.6	-0.64	-0.95	-0.47	-0.65	-0.65	0.33	-0.67	-0.43		-0.68
Property Plant Equipment	0.94	0.95	0.92	0.43	-0.7	0.86	0.87	0.72	0.85	0.71	0.94	0.91	-0.73	0.94	-0.05	-0.68

Click cells to compare fundamentals

About Iteos Therapeutics Financial Statements

Iteos Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Iteos Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Iteos Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Iteos Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	667.6 M	496.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Iteos Stock Analysis

When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC